Tuhin, Md Tariqul Haque
Liang, Dengpan http://orcid.org/0000-0001-9898-1836
Liu, Fang
Aldawod, Hala
Amin, Toufiq Ul http://orcid.org/0000-0002-9093-4856
Ho, Joshua S.
Emara, Rasha
Patel, Arjun D.
Felmlee, Melanie A.
Park, Miki S.
Uchizono, James A. http://orcid.org/0000-0002-5896-3905
Alhamadsheh, Mamoun M. http://orcid.org/0000-0003-4325-7044
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (1R15GM129676-01)
Article History
Received: 12 January 2022
Accepted: 14 June 2022
First Online: 23 June 2022
Competing interests
: M.M.A. is a cofounder and shareholder of Eidos Therapeutics, a company developing AG10 to treat TTR Amyloid Cardiomyopathy. All other authors declare that they have no competing interests.